Kennedy Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-344,042
| Closed | -$1.57M | – | 697 |
|
|
2023
Q3 | $1.57M | Buy |
344,042
+118,133
| +52% | +$538K | 0.04% | 503 |
|
|
2023
Q2 | $1.59M | Sell |
225,909
-182,567
| -45% | -$1.29M | 0.04% | 500 |
|
|
2023
Q1 | $2.5M | Sell |
408,476
-154,659
| -27% | -$945K | 0.07% | 374 |
|
|
2022
Q4 | $3.6M | Sell |
563,135
-110,491
| -16% | -$706K | 0.1% | 336 |
|
|
2022
Q3 | $6.45M | Buy |
673,626
+9,178
| +1% | +$87.9K | 0.19% | 185 |
|
|
2022
Q2 | $7.34M | Buy |
664,448
+230,990
| +53% | +$2.55M | 0.21% | 178 |
|
|
2022
Q1 | $7.22M | Buy |
433,458
+20,758
| +5% | +$346K | 0.17% | 218 |
|
|
2021
Q4 | $7.88M | Sell |
412,700
-11,501
| -3% | -$220K | 0.17% | 229 |
|
|
2021
Q3 | $10.5M | Buy |
424,201
+47,282
| +13% | +$1.17M | 0.23% | 136 |
|
|
2021
Q2 | $9.81M | Buy |
376,919
+339,486
| +907% | +$8.83M | 0.21% | 167 |
|
|
2021
Q1 | $1.19M | Sell |
37,433
-3,759
| -9% | -$119K | 0.02% | 541 |
|
|
2020
Q4 | $1.91M | Sell |
41,192
-397
| -1% | -$18.4K | 0.04% | 510 |
|
|
2020
Q3 | $1.37M | Sell |
41,589
-319
| -0.8% | -$10.5K | 0.04% | 521 |
|
|
2020
Q2 | $1.15M | Buy |
41,908
+280
| +0.7% | +$7.68K | 0.03% | 564 |
|
|
2020
Q1 | $1.25M | Sell |
41,628
-11,037
| -21% | -$330K | 0.05% | 529 |
|
|
2019
Q4 | $1.46M | Sell |
52,665
-461
| -0.9% | -$12.8K | 0.04% | 586 |
|
|
2019
Q3 | $967K | Sell |
53,126
-21,525
| -29% | -$392K | 0.02% | 595 |
|
|
2019
Q2 | $1.83M | Buy |
+74,651
| New | +$1.83M | 0.04% | 550 |
|